On the 29th of April 2009 the Annual General Shareholders Meeting of Vilniaus baldai AB adopted the following resolutions: Item1 of the Agenda: Consolidated annual report.The meeting listened the Company‘s consolidated..
MoreAshwin Roy was elected as the chairman of Sanitas AB Management Board on April 28, 2009
MoreCompany‘s auditor‘s report was presented to the shareholders, consolidated annual report, Company‘s financial statements, consolidated financial statements and Company‘s profit (loss) distribution for 2008 were approved during Sanitas AB (hereinafter..
MoreSanitas AB Management Board member Vytautas Bucas resigns from April 23, 2009.
MoreState Medicines Control Agency to the Ministry of Health of Republic of Lithuania (hereinafter – SMCA) inspected Sanitas AB pharmaceutical activity‘s compliance to the requirements of Good Manufacture Practice (hereinafter..
MoreNet profit of Vilniaus baldai AB during December 2008 was 13.05 million LTL (3.78 million EUR), December of previous year net loss was 813 thousand LTL (236 thousand EUR). EBITDA..
MoreTurnover of Vilniaus Baldai AB during December 2008 was 10 402 thousand LTL (3 013 thousand EUR), December of previous year – 11 249 thousand LTL (3 258 thousand EUR). Turnover..
MoreState Medicines Control Agency to the Ministry of Health of Republic of Lithuania (hereinafter – SMCA) inspected Sanitas AB pharmaceutical activity‘s compliance to the requirements of good manufacture practice. In..
MoreSanitas AB through its subsidiary Jelfa SA acquired 100 % stock of shares in Polish ointment producer Homeofarm sp.z.o.o. The shares purchase agreement was executed on 23.12.2008 between Jelfa SA..
More